Search Results

There are 12087 results for: content related to: Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Headache: Subgroup Analysis of Patients Not Receiving Other Prophylactic Medications: A Randomized Double-Blind, Placebo-Controlled Study

  1. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE)

    Intervention Review

    The Cochrane Library

    Brian J Hoare, Margaret A Wallen, Christine Imms, Elmer Villanueva, Hyam Barry Rawicki and Leeanne Carey

    Published Online : 20 JAN 2010, DOI: 10.1002/14651858.CD003469.pub4

  2. You have free access to this content
    Receptor-mediated transcytosis of botulinum neurotoxin A through intestinal cell monolayers

    Cellular Microbiology

    Volume 10, Issue 2, February 2008, Pages: 375–387, Aurélie Couesnon, Yannick Pereira and Michel R. Popoff

    Version of Record online : 17 SEP 2007, DOI: 10.1111/j.1462-5822.2007.01051.x

  3. You have free access to this content
    Beyond muscular effects: depression of spinal recurrent inhibition after botulinum neurotoxin A

    The Journal of Physiology

    Volume 591, Issue 4, February 2013, Pages: 1017–1029, Véronique Marchand-Pauvert, Claire Aymard, Louis-Solal Giboin, Federica Dominici, Alessandro Rossi and Riccardo Mazzocchio

    Version of Record online : 2 NOV 2012, DOI: 10.1113/jphysiol.2012.239178

  4. You have free access to this content
    Traffic of Botulinum Toxins A and E in Excitatory and Inhibitory Neurons

    Traffic

    Volume 8, Issue 2, February 2007, Pages: 142–153, Claudia Verderio, Carlotta Grumelli, Luca Raiteri, Silvia Coco, Silvio Paluzzi, Paola Caccin, Ornella Rossetto, Giambattista Bonanno, Cesare Montecucco and Michela Matteoli

    Version of Record online : 28 NOV 2006, DOI: 10.1111/j.1600-0854.2006.00520.x

  5. You have full text access to this OnlineOpen article
    Translocation of botulinum neurotoxin serotype A and associated proteins across the intestinal epithelia

    Cellular Microbiology

    Volume 17, Issue 8, August 2015, Pages: 1133–1143, Tina I. Lam, Larry H. Stanker, Kwangkook Lee, Rongsheng Jin and Luisa W. Cheng

    Version of Record online : 15 FEB 2015, DOI: 10.1111/cmi.12424

  6. Acute and chronic effects of botulinum neurotoxin a on the mammalian neuromuscular junction

    Muscle & Nerve

    Volume 50, Issue 2, August 2014, Pages: 206–215, Padmamalini Baskaran and Baskaran Thyagarajan

    Version of Record online : 9 MAY 2014, DOI: 10.1002/mus.24119

  7. You have free access to this content
    Molecular structures and functional relationships in clostridial neurotoxins

    The FEBS Journal

    Volume 278, Issue 23, December 2011, Pages: 4467–4485, Subramanyam Swaminathan

    Version of Record online : 13 JUN 2011, DOI: 10.1111/j.1742-4658.2011.08183.x

  8. You have full text access to this OnlineOpen article
    Recovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin A

    The Journal of Physiology

    Volume 586, Issue 13, July 2008, Pages: 3163–3182, A. A. Rogozhin, K. K. Pang, E. Bukharaeva, C. Young and C. R. Slater

    Version of Record online : 28 JUN 2008, DOI: 10.1113/jphysiol.2008.153569

  9. Botulinum Toxin Type A (BOTOX®) for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double-Blind, Placebo-Controlled Trial

    Headache: The Journal of Head and Face Pain

    Volume 45, Issue 4, April 2005, Pages: 293–307, Ninan T. Mathew, Benjamin M. Frishberg, Marek Gawel, Rozalina Dimitrova, John Gibson, Catherine Turkel and BOTOX CDH Study Group

    Version of Record online : 5 APR 2005, DOI: 10.1111/j.1526-4610.2005.05066.x

  10. Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement

    European Journal of Neurology

    Volume 17, Issue s2, August 2010, Pages: 9–37, S. C. Love, I. Novak, M. Kentish, K. Desloovere, F. Heinen, G. Molenaers, S. O’Flaherty and H. K. Graham

    Version of Record online : 15 JUL 2010, DOI: 10.1111/j.1468-1331.2010.03126.x

  11. You have free access to this content
    Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor

    Journal of Neurochemistry

    Volume 110, Issue 6, September 2009, Pages: 1942–1954, Andreas Rummel, Kirstin Häfner, Stefan Mahrhold, Natallia Darashchonak, Matthew Holt, Reinhard Jahn, Silke Beermann, Tino Karnath, Hans Bigalke and Thomas Binz

    Version of Record online : 23 JUL 2009, DOI: 10.1111/j.1471-4159.2009.06298.x

  12. The Strange Case of the Botulinum Neurotoxin: Using Chemistry and Biology to Modulate the Most Deadly Poison

    Angewandte Chemie International Edition

    Volume 47, Issue 44, October 20, 2008, Pages: 8360–8379, Bert Willis, Lisa M. Eubanks, Tobin J. Dickerson and Kim D. Janda

    Version of Record online : 7 OCT 2008, DOI: 10.1002/anie.200705531

  13. You have free access to this content
    Unique ganglioside binding by botulinum neurotoxins C and D-SA

    The FEBS Journal

    Volume 278, Issue 23, December 2011, Pages: 4486–4496, Abby R. Kroken, Andrew P.-A. Karalewitz, Zhuji Fu, Michael R. Baldwin, Jung-Ja P. Kim and Joseph T. Barbieri

    Version of Record online : 31 MAY 2011, DOI: 10.1111/j.1742-4658.2011.08166.x

  14. You have free access to this content
    Proteolysis of SNAP-25 Isoforms by Botulinum Neurotoxin Types A, C, and E

    Journal of Neurochemistry

    Volume 72, Issue 1, January 1999, Pages: 327–337, Vadakkanchery V Vaidyanathan, Ken-ichi Yoshino, Michael Jahnz, Christos Dörries, Steffen Bade, Sonja Nauenburg, Heiner Niemann and Thomas Binz

    Version of Record online : 18 JAN 2002, DOI: 10.1046/j.1471-4159.1999.0720327.x

  15. You have free access to this content
    Therapeutic use of botulinum toxin in migraine: mechanisms of action

    British Journal of Pharmacology

    Volume 171, Issue 18, September 2014, Pages: 4177–4192, Roshni Ramachandran and Tony L Yaksh

    Version of Record online : 28 AUG 2014, DOI: 10.1111/bph.12763

  16. You have free access to this content
    Persistence of botulinum neurotoxin action in cultured spinal cord cells 1,2

    FEBS Letters

    Volume 456, Issue 1, July 30, 1999, Pages: 137–142, James E Keller, Elaine A Neale, George Oyler and Michael Adler

    Version of Record online : 28 JUL 1999, DOI: 10.1016/S0014-5793(99)00948-5

  17. You have free access to this content
    Differential entry of botulinum neurotoxin A into neuronal and intestinal cells

    Cellular Microbiology

    Volume 11, Issue 2, February 2009, Pages: 289–308, Aurélie Couesnon, Takeshi Shimizu and Michel R. Popoff

    Version of Record online : 31 OCT 2008, DOI: 10.1111/j.1462-5822.2008.01253.x

  18. Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction

    European Journal of Neuroscience

    Volume 10, Issue 8, August 1998, Pages: 2617–2628, Dorota A. Raciborska, 1 William S. Trimble and 2 Milton P. Charlton 1

    Version of Record online : 21 APR 2002, DOI: 10.1046/j.1460-9568.1998.00270.x

  19. You have free access to this content
    Exchange of the HCC domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin

    The FEBS Journal

    Volume 278, Issue 23, December 2011, Pages: 4506–4515, Andreas Rummel, Stefan Mahrhold, Hans Bigalke and Thomas Binz

    Version of Record online : 22 JUN 2011, DOI: 10.1111/j.1742-4658.2011.08196.x

  20. Understanding peptide competitive inhibition of botulinum neurotoxin a binding to SV2 protein via molecular dynamics simulations

    Biopolymers

    Volume 103, Issue 10, October 2015, Pages: 597–608, Shan Chang, Hong-Qiu He, Lin Shen and Hua Wan

    Version of Record online : 24 JUL 2015, DOI: 10.1002/bip.22682